Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001669866-26-000007

CEO AND PRESIDENT acquired 65,292 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garcia Marino CEO AND PRESIDENT 2026-03-16 Option exercise +59,700 $6.70 $399,990 59,700 D: show line 1 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-16 Option exercise +5,592 $17.88 $99,985 65,292 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garcia Marino CEO AND PRESIDENT 2026-03-16 Option exercise · Stock Option (Right to Buy) −59,700 41 D: show line 3 in the form
Garcia Marino CEO AND PRESIDENT 2026-03-16 Option exercise · Stock Option (Right to Buy) −5,592 269,408 D: show line 4 in the form
Loading xslF345X05/ownership.xml…